Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1486741

GTEX

db836bf9-3bda-5c62-a2ae-da462ba82a91

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • DNA_REPAIR+0.121
  • KRAS_SIGNALING_DN+0.024
  • MITOTIC_SPINDLE+0.020
  • PROTEIN_SECRETION+0.001
  • MYC_TARGETS_V2-0.039
  • PI3K_AKT_MTOR_SIGNALING-0.039
  • UNFOLDED_PROTEIN_RESPONSE-0.046
  • SPERMATOGENESIS-0.053
  • MYC_TARGETS_V1-0.084
  • HEME_METABOLISM-0.090

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.589
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.523
  • INTERFERON_GAMMA_RESPONSE-0.518
  • TNFA_SIGNALING_VIA_NFKB-0.507
  • TGF_BETA_SIGNALING-0.500
  • INFLAMMATORY_RESPONSE-0.490
  • NOTCH_SIGNALING-0.479
  • IL6_JAK_STAT3_SIGNALING-0.474
  • ANGIOGENESIS-0.451
  • APOPTOSIS-0.446

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1338323
brain-umap@2
GTEX0.987
2SRR1429935
brain-umap@2
GTEX0.987
3SRR1476632
brain-umap@2
GTEX0.986
4SRR1317808
brain-umap@2
GTEX0.985
5SRR1331841
brain-umap@2
GTEX0.984
6SRR1340095
brain-umap@2
GTEX0.984
7SRR1475737
brain-umap@2
GTEX0.983
8SRR1490382
brain-umap@2
GTEX0.982
9SRR1456841
brain-umap@2
GTEX0.982
10SRR1434782
brain-umap@2
GTEX0.982

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
DNA_REPAIR0.121Idelalisib— uncovered
KRAS_SIGNALING_DN0.024Remibrutinib— uncovered
MITOTIC_SPINDLE0.020Inavolisib— uncovered
PROTEIN_SECRETION0.001Remibrutinib— uncovered